Exosomes: Basic biology and technological advancements suggesting their potential as ischemic heart disease therapeutics
Author(s)
Shanmuganathan, Mayooran
Vughs, Jeff
Noseda, Michela
Emanueli, Costanza
Type
Journal Article
Abstract
Exosomes are small nano-sized vesicles that deliver biologically active RNA molecules and proteins to recipient cells through binding, fusion or endocytosis. There is emerging evidence that endogenous exosomes released by cardiovascular cells and progenitor cells impact cell survival and proliferation, thus regulating angiogenesis, cardiac protection and repair. These cardioprotective and regenerative traits have the potential to translate in to novel therapeutic options for post-ischaemic cardiac regeneration, thus potentially delaying the progression to ischaemic heart failure. Cellular stressors influence exosomes' secretion and the molecular composition of the exosome cargo, thus impacting on the above processes. Evidences are emerging that loading of proteins and RNAs in the exosomes cargos can be manipulated. Similarly, manipulation of exosomes surface proteins' expression to target exosomes to specific cells and tissues is doable. In addition, nature-inspired synthetic exosomes can be assembled to deliver specific clues to the recipient cells, including proliferative and differentiation stimuli, or shed paracrine signals enabling to reconstructing the heart homeostatic micro-environment. This review will describe exosome biogenesis and emerging evidence of exosome-mediated regenerative cell-to-cell communications and will conclude discussing possibilities of using exosomes to treat ischemic heart disease.
Date Issued
2018-11-19
Date Acceptance
2018-08-02
Citation
Frontiers in Physiology, 2018, 9
ISSN
1664-042X
Publisher
Frontiers Media
Journal / Book Title
Frontiers in Physiology
Volume
9
Copyright Statement
© 2018 Shanmuganathan, Vughs, Noseda and Emanueli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY - https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450537000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Physiology
exosomes
microRNAs
precision medicine
stem cells
synthetic biology
ischemic disease
angiogenesis
heart failure
STEM-CELL THERAPY
ACUTE MYOCARDIAL-INFARCTION
EXTRACELLULAR VESICLES
CARDIOVASCULAR-DISEASE
ISCHEMIC-MYOCARDIUM
DIABETES-MELLITUS
DENDRITIC CELLS
CIRCULATING MICRORNAS
CORONARY INTERVENTION
MEDIATED ENDOCYTOSIS
Publication Status
Published
Article Number
1159
Date Publish Online
2018-11-19